2002
DOI: 10.1212/wnl.58.5.824
|View full text |Cite
|
Sign up to set email alerts
|

Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS

Abstract: The authors studied the intrathecal IgM synthesis (ITMS) in paired sera and CSF samples from 65 patients with MS, 28 with CNS infection, 40 with other neurologic diseases and eight control subjects. ITMS was found in 30 patients with MS and in 20 with CNS infection, but not in patients with other neurologic diseases or in control subjects. In infectious samples, the ITMS is likely a primary response. In MS group, it was associated with higher Expanded Disability Status Scale index (p = 0.017).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
60
0
1

Year Published

2002
2002
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(68 citation statements)
references
References 10 publications
7
60
0
1
Order By: Relevance
“…The presence of CSF-restricted OCMBs seems to be characteristic of these MS patients throughout the course of the disease (13,14) and is associated with a more aggressive disease course (11,12,14). Sustained IgM responses like this are usually produced by the long-lived CD5 + subset of B lymphocytes (19), which is increased in CSF of patients with aggressive forms of MS (21).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The presence of CSF-restricted OCMBs seems to be characteristic of these MS patients throughout the course of the disease (13,14) and is associated with a more aggressive disease course (11,12,14). Sustained IgM responses like this are usually produced by the long-lived CD5 + subset of B lymphocytes (19), which is increased in CSF of patients with aggressive forms of MS (21).…”
Section: Discussionmentioning
confidence: 99%
“…With this method, intrathecal IgM synthesis has been detected in a subgroup of MS patients (11,12). These IgM bands usually persist in MS patients throughout the course of the disease (13,14) and are an unfavorable prognostic marker (14).…”
Section: Ms Is a Demyelinating Disease Of The Cns Of Unknown Etiologymentioning
confidence: 99%
“…Immunohistologic studies indicate immune effector functions for plaque IgG (3)(4)(5)(6)(7) and MS patients with a high B cell-to-monocyte ratio in cerebrospinal fluid (CeSF) show a more rapid disease progression (8). Oligoclonal IgM bands are also present in CeSF of some MS patients and correlate with a more aggressive form of disease (9,10). Phenotypic analyses of B cell subsets and sequence analyses of Ig V regions expressed by B and plasma cells in MS CeSF and brain indicate a T cell-dependent Ag-specific response (reviewed in Ref.…”
Section: Ultiple Sclerosis (Ms)mentioning
confidence: 99%
“…Elevated intrathecal Ig has been associated with poorer MS prognosis (44,45) . In particular, anti-lipid IgM is associated with enhanced early disease activity and worse prognosis (46) . The advent of rituximab, a monoclonal antibody therapy that specifi cally lyses B cells, confi rmed the key role of B cells and their products in MS. Rituximab targets CD20, a cell surface molecule confi ned to B cells, leading to depletion of circulating B cell.…”
Section: Cd4mentioning
confidence: 99%